Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy-Reference-Cited by-同舟云学术

Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy

Published:2020-03-18 Issue:2 Volume:33 Page:
ISSN:0893-8512
Container-title:Clinical Microbiology Reviews
language:en
Short-container-title:Clin Microbiol Rev

Author:

Nguyen Mindie H.¹,Wong Grace²,Gane Edward³⁴,Kao Jia-Horng⁵⁶⁷,Dusheiko Geoffrey⁸

Affiliation:

1. Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA

2. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong

3. New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand

4. Department of Medicine, University of Auckland, Auckland, New Zealand

5. Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei, Taiwan

6. Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei, Taiwan

7. Hepatitis Research Center, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei, Taiwan

8. UCL Medical School, Kings College Hospital, London, United Kingdom

Abstract

Currently, despite the use of a preventive vaccine for several decades as well as the use of effective and well-tolerated viral suppressive medications since 1998, approximately 250 million people remain infected with the virus that causes hepatitis B worldwide. Hepatitis C virus (HCV) and hepatitis B virus (HBV) are the leading causes of liver cancer and overall mortality globally, surpassing malaria and tuberculosis. Linkage to care is estimated to be very poor both in developing countries and in high-income countries, such as the United States, countries in Western Europe, and Japan.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology

Link

https://journals.asm.org/doi/pdf/10.1128/CMR.00046-19

Reference271 articles.

1. Global control of hepatitis B virus infection

2. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

3. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

4. Chronic Hepatitis B Prevalence Among Foreign‐Born and U.S.‐Born Adults in the United States, 1999‐2016

5. The Increasing Burden of Imported Chronic Hepatitis B — United States, 1974–2008

Cited by 243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing public health policies to combat Hepatitis B in Africa: Challenges, advances, and recommendations for meeting 2030 targets;Journal of Medicine, Surgery, and Public Health;2024-04

2. Expanding the Donor Pool for Liver Transplantation: Assessing the Potential Use of HBV-Positive Allografts;Current Hepatology Reports;2024-02-06

3. Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy;ACS Omega;2024-02-05

4. Hepatitis B virus evades the immune system by suppressing the NF-κB signaling pathway with DENND2A;Microbiology Spectrum;2024-01-19

5. Identification of associated risk factors for serological distribution of hepatitis B virus via machine learning models;BMC Infectious Diseases;2024-01-09